UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040711
Receipt number R000046474
Scientific Title Effectiveness of the low-cost, portable, BUBBLE INCUBATOR for premature neonates in Republic of Sierra Leone
Date of disclosure of the study information 2020/06/10
Last modified on 2020/06/10 15:45:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of the low-cost, portable, BUBBLE INCUBATOR for premature neonates in Republic of Sierra Leone

Acronym

Effectiveness of the low-cost, portable, BUBBLE INCUBATOR for premature neonates in Republic of Sierra Leone

Scientific Title

Effectiveness of the low-cost, portable, BUBBLE INCUBATOR for premature neonates in Republic of Sierra Leone

Scientific Title:Acronym

Effectiveness of the low-cost, portable, BUBBLE INCUBATOR for premature neonates in Republic of Sierra Leone

Region

Africa


Condition

Condition

premature neonates

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study evaluated a low-cost portable bubble incubator (Atom Medical Inc, Tokyo, Japan) that does not require an electric power supply for neonatal intensive care at Ola During Children's Hospital, a tertiary care children's hospital in Sierra Leone.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome was the time that the body temperature remained at or above 36.5 degrees.

Key secondary outcomes

The secondary outcome that the temperature inside the incubator remained at or above 34 degrees.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The study was conducted over two weeks between January 8 and 27, 2020. Neonates weighing 800 to 2000gram, with stable respiration and born at Ola During Children's Hospital were enrolled. Heart rate and SpO2 were continuously measured by pulse oximeters on the wrist or sole of the neonates. The same type of thermometer was used to measure the temperatures inside the bubble incubator, outside the bubble incubator, and the surface temperature of the hot water container insulation. The axillary temperature of the neonate was measured. The temperature inside the bubble incubator was measured by a probe positioned at its center. The probe for measuring the external temperature was positioned at the same height as the incubator. The oxygen concentration in the bubble incubator was measured by an oximeter placed approximately 10 cm above the mouth of the neonate. An oximeter rather than a CO2 meter was used for reasons of safety. A cylinder of water was heated when the temperature inside the bubble incubator was 32degees or less or the body temperature was 36.5 degrees or less. The body temperature of the newborns was measured every 4 hours for 24 hours before the start of the research. Body temperature, the temperature inside and outside the bubble incubator, and the surface temperature of the insulation around the water containers were measured every 15 minutes after the start of the study or turning the water heater on. The measurements were continued hourly unless the bubble incubator and body temperatures became too high. The neonates were taken out of the bubble incubator after 22 hours, and returned to a cot with monitoring of their body temperature and the environmental temperature of the intensive care unit every 4 hours for 24 hours.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Newborn admitted to Ola During Children's Hospital.
Newborns from 800g to 2000g.
Written informed consent of the patient or his/her formal representative.

Key exclusion criteria

When informed consent cannot be obtained.
Newborns with fatal congenital diseases.
Newborns with critical conditions (breathing disorder, sepsis).
Newborns under 800g over 2000g.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Shuusaku
Middle name
Last name Kobori

Organization

Funabashi Central Hospital

Division name

Perinatal Center

Zip code

273-8556

Address

6-13-10 Kaijin, Funabashi City, Chiba

TEL

0474332111

Email

kobochannurann9@yahoo.co.jp


Public contact

Name of contact person

1st name Shuusaku
Middle name
Last name Kobori

Organization

Funabashi Central Hospital

Division name

Perinatal Center

Zip code

273-8556

Address

6-13-10 Kaijin, Funabashi City, Chiba

TEL

0474332111

Homepage URL


Email

kobochannurann9@yahoo.co.jp


Sponsor or person

Institute

Funabashi Central Hospital

Institute

Department

Personal name



Funding Source

Organization

Atom Medical Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sierra Leone Ethics and Scientific Review Committee

Address

Ministry of Health and Sanitation Directorate of Policy, Planning & Information (DPPI) Youyi Building, Fifth Floor, East Wing

Tel

23278366493

Email

efoday@health.gov.sl


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Ola During Children's Hospital


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

5

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 28 Day

Date of IRB

2020 Year 01 Month 09 Day

Anticipated trial start date

2020 Year 01 Month 09 Day

Last follow-up date

2020 Year 01 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 10 Day

Last modified on

2020 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046474


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name